Ligand Pharmaceuticals reported $153.22M in Cash and Equivalent for its second fiscal quarter of 2022.

Trading Economics members can view, download and compare data from nearly 200 countries, including more than 20 million economic indicators, exchange rates, government bond yields, stock indexes and commodity prices.

The Trading Economics Application Programming Interface (API) provides direct access to our data. It allows API clients to download millions of rows of historical data, to query our real-time economic calendar, subscribe to updates and receive quotes for currencies, commodities, stocks and bonds.

Please Paste this Code in your Website
Cash And Equivalent Change
Acorda Therapeutics ACOR:US $ 23.13M 8.75M
Agenus AGEN:US $ 228.38M 19.32M
Amgen AMGN:US $ 5203M 1325M
Anika Therapeutics ANIK:US $ 91.39M 1.07M
Arrowhead Research ARWR:US $ 139.44M 53.03M
Baxter International BAX:US $ 1852M 442M
Bristol Myers Squibb BMY:US $ 10750M 1619M
Clovis Oncology CLVS:US $ 94.58M 27.66M
Eli Lilly And LLY:US $ 2622.9M 163.7M
Enanta Pharmaceuticals ENTA:US $ 28.37M 12.62M
Endo International Ordinary Shares ENDP:US $ 1191.57M 221.58M
Gilead Sciences GILD:US $ 7000M 2704M
Glaxosmithkline GSK:US $ 6465M 4502M
GlaxoSmithKline GSK:LN 6465M 4502M
Harsco HSC:US $ 96.78M 11.57M
Heron Therapeutics HRTX:US $ 48.61M 8.3M
Immunogen IMGN:US $ 373.87M 63.79M
Insmed INSM:US $ 416.08M 99.63M
Intrexon XON:US $ 43.84M 3.52M
Karyopharm Therapeutics KPTI:US $ 82.25M 71.01M
Lannett LCI:US $ 106.11M 7.47M
Ligand Pharmaceuticals LGND:US $ 153.22M 138.22M
Macrogenics MGNX:US $ 21.47M 25.86M
Pacira Pharmaceuticals PCRX:US $ 122.06M 104.69M
Rigel Pharmaceuticals RIGL:US $ 27.2M 2.52M
Sangamo Biosciences SGMO:US $ 117.7M 2.55M
Spectrum Pharmaceuticals SPPI:US $ 25.51M 53.17M
Teva Pharmaceutical Industries TEVA:US $ 2058M 117M
Veracyte VCYT:US $ 153.45M 10.17M